Topic
Pharmexcil
PHARMEXCIL draws robust growth roadmap for India’s generic pharmaceutical exports
The PHARMEXCIL delegation comprised Namit Joshi, Chairman; Nipun Jain, Chairman – iPHEX 2026 & MSME Committee; and Raja Bhanu, Director…
India well-positioned to evolve as an innovation-led pharma nation over next five years: CDSCO
At the 18th CPHI & PMEC India Expo 2025, CDSCO Joint Drugs Controller highlighted the government scheme & CDSCO reforms…
Pharmexcil Calls for GST Parity Between APIs and Formulations to Address Inverted Duty Structure
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has urged the government to align Goods and Services Tax (GST) rates…
Pharmexcil to organise iPHEX 2025
The event will be held from September 4–6, 2025, at Bharat Mandapam, New Delhi iPHEX 2025, the 11th Edition of…
India Eyes $1 Trillion Drug Exports by 2030, With Biosimilars at the Helm
India’s pharmaceutical sector is betting big on biosimilars to drive future exports and shift toward higher-value global markets. Biosimilars are…
India’s Pharma Export Boom: A $65 Bn Dream or an Unattainable Mirage?
India’s pharmaceutical industry is poised for significant growth, targeting $65 billion in exports by 2030 and $350 billion by 2047.…
PHARMEXCIL strengthens India-UAE partnership in pharma
PHARMEXCIL will host the India Pavilion at Arab Health 2025 The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) strengthened the…
14th edition of the CPhI & P-MEC India Expo set to open opportunities for India’s pharma market
The event will be held from November 24 to 26, 2021 at the India Expo Centre, Greater Noida, Delhi –…
Hyderabad likely to emerge as global hub for COVID vaccine
The city-based firms also played a crucial role in providing bulk drugs and formulations As the world is set to…